Page last updated: 2024-11-01

octopamine and Cancer of Liver

octopamine has been researched along with Cancer of Liver in 2 studies

Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ma, B1
Li, J1
Yang, WK1
Zhang, MG1
Xie, XD1
Bai, ZT2
Wu, ZR1
Xi, LL1
Li, X1
Chen, P1
Wang, FQ1
Meng, WB1
Zhou, WC1
Wu, XA1
Yao, XJ1
Zhang, M1

Other Studies

2 other studies available for octopamine and Cancer of Liver

ArticleYear
N-
    Analytical cellular pathology (Amsterdam), 2021, Volume: 2021

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Prolifer

2021
Inhibition of invasion by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cells.
    Bioorganic & medicinal chemistry letters, 2017, 02-15, Volume: 27, Issue:4

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Coumaric Acids; Epithelial-Mesenchymal Transition; Huma

2017